Related Articles
Higher expression of circulating miR‑182 as a novel biomarker for breast cancer
Identification of circulating microRNA signatures for upper tract urothelial carcinoma detection
Circulating microRNA‑103a‑3p could be a diagnostic and prognostic biomarker for breast cancer
Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription‑quantitative polymerase chain reaction in patients with bladder cancer
Decreased serum miR-181a is a potential new tool for breast cancer screening